Latest Interview with Leslie Chong

Hi y'all

So this is worth a look. Leslie is in Vegas at a "Micro Cap" conference. Apparently what happens in Vegas doesn't stay in Vegas after all, because now we have a brief but interesting interview to watch. Points to note:
From 1:50 - 2:15 she gives a summary of Imugene's competitive advantage, stating that the B cell vaccine's have a huge advantage in terms of no toxicity but including this statement - "our cancer vaccines have proven a lot of efficacy as well as safety.."
Also 3:10 to 3:30. "So we have phenomenal response rates coming out of our phase 1b..."

Those who are unimpressed by Imugene will remain unimpressed.
Myself, I see encouraging results in the trials so far, huge confidence coming from the management team, recent additions to the Board which build enormous deal making capability and a share price which makes it a bargain buy for those willing to take a risk.
But hey - that's just me.
Cheers
Dave